Beijing Tiantan Biological Products Co., Ltd. provided earnings guidance for the year 2018. The company predicted a decrease of RMB 683,160,000 in the net profit belonging to shareholders of the listed company in 2018 compared with the same period of the year before and with a year-on-year decrease of about 58% (based on the disclosed statistics according to relevant regulations). The company predicted a decrease of RMB 676,390,000 in the net profit belonging to shareholders of the listed company compared with the same period of the year before and with a year-on-year decrease of about 58% (reiterated and adjusted data). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by RMB 78,830,000 compared with the year before, with a year-on-year increase of about 19% (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by RMB 78,830,000 compared with the same period of the year before, with a year-on-year increase of about 19%.